Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: A Pediatric Oncology Group report

Leukemia

Volumn 14, Issue 3, 2000, Pages 369-373

  Laver, J H ^a   Barredo, J C ^a   Amylon, M ^b   Schwenn, M ^c   Kurtzberg, J ^d   Camitta, B M ^e   Pullen, J ^f   Link, M P ^b   Borowitz, M ^g   Ravindranath, Y ^h   Murphy, S B ⁱ   Shuster, J ^j  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d DUKE UNIVERSITY   (United States)

^e Midwest Children's Cancer Center   (United States)

^f UNIVERSITY OF MISSISSIPPI   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

ⁱ CHILDREN'S MEMORIAL HOSPITAL   (United States)

^j UNIVERSITY OF FLORIDA   (United States)

more..

Author keywords

Childhood acute lymphoblastic leukemia; Cranial radiation; T cell leukemia

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PODOPHYLLOTOXIN; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; SKULL IRRADIATION; T CELL LEUKEMIA;

EID: 0034009371     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401693     Document Type: Article

References (29)

1. Falletta JM, Shuster JJ, Crist WM, Pullen DJ, Borowitz MJ, Wharam M, Patterson R, Foreman E, Vietti TJ. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T cell leukemia: a Pediatric Oncology Group study. Leukemia 1992; 6: 541-546.
2. Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB. Intensive high dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: Pediatric Oncology Group study 8704. Leukemia 1999; 13: 335-342.
3. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18-24.
4. Shuster JJ, Falletta JM, Pullen DJ, Crist WM, Humphrey GB, Dowell BL, Wharam MD, Borowitz M. Prognostic factors in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1990; 75: 166-173.
5. Pullen J, Boyett J, Shuster J, Crist W, Land V, Frankel L, Iyer R, Backstrom L, Van Eys J, Harris M, Ravindranath Y, Sullivan M. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1993; 11: 839-849.
6. Conter V, Schrappe M, Arico' A, Reiter A, Rizzari C, Dordelmann M, Valsecchi MG, Zimmermann M, Ludwig WD, Basso G, Masera G, Riehm H. Role of cranial radiotherapy for childhood T cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. J Clin Oncol 1997; 15: 2786-2791.
7. Pui C-H, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK, Kalwinsky DK, Sandlund JT, Crist WM, Raimondi SC. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T cell acute lymphoblastic leukemia. Blood 1990; 75: 174-178.
8. Arico M, Basso G, Mandelli F, Rizzari C, Colella R, Barisone E, Zanesco L, Rondelli R, Pession A, Masera G. Good steroid response in vivo predicts a favorable outcome in children with T cell acute lymphoblastic leukemia. Cancer 1995; 75: 1684-1693.
9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-458.
10. Pui C-H, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343-362.
11. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 35: 457-481.
13. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia. 30 years' experience at St Jude Children's Research Hospital. New Engl J Med 1993; 329: 1289-1295.
14. Rimm IJ, Li FC, Tarbell NJ, Winston DR, Sallan SE. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13-year experience from the Dana-Farber Cancer Institute and The Children's Hospital. Cancer 1987; 59: 1506-1508.
15. Brouwers P, Poplack D. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am J Ped Hematol/Oncol 1990; 12: 174-181.
16. Nachman J, Sather HN, Cherlow JM, Sensel MG, Gaynon PS, Lukens JN, Wolff L, Trigg ME. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 920-930.
17. Pui C-H, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG, Head DR, Relling MV, Ribeiro PC, Rubnitz JE, Kun LE, Evans WE. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1999; 92: 411-415.
18. Uckun FM, Sensel MG, Sun L, Steinherz PG, Trigg ME, Heerema NA, Sather HN, Reaman GH, Gaynon PS. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood 1998; 91: 735-746.
19. Early AP, Preisler HD, Slocum H, Rustum YM. A pilot study of high-dose 1-β-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Cancer Res 1982; 42: 1587-1594.
20. Shapiro WR, Young DG, Mehta BM. Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular, and lumbar injections. New Engl J Med 1975; 293: 161-166.
21. Freeman AI, Weinberg V, Brecher ML, Jones B, Glicksman AS, Sinks LF, Weil M, Pleuss H, Hananian J, Burgert EO, Gilchrist GS, Necheles T, Harris M, Kung F, Patterson RB, Maurer H, Leventhal B, Chevalier L, Forman E, Holland JF. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. New Engl J Med 1983; 308: 477-484.
22. Ritchey AK, Pollock BH, Lauer SJ, Andejeski Y, Barredo J, Buchanan GR. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia. A Pediatric Oncology Group study. J Clin Oncol 1999; 17: 3745-3752.
23. Thompson CB, Sanders JE, Flournoy N, Buckner CD, Thomas ED. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Stood 1986; 67: 195-199.
24. Pullen DJ, Sullivan MP, Falletta JM, Boyett JM, Humphrey GB, Starling KA, Land VJ, Dyment PG, Vats T, Duncan MH. Modified LSA2-L2 treatment in 53 children with E-rosette-positive T cell leukemia: results and prognostic factors (a Pediatric Oncology Group study). Blood 1982; 60: 1159-1168.
25. Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Ganynon PS. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. New Engl J Med 1998; 338: 1663-1671.
26. Reiter A, Schrappe M, Ludwig WD, Hiddenmann W, Sauter S, Henze G, Zimmerman M, Lampert F, Havers W, Niethammer D et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
27. Shuster JJ. Publishing clinical trials and dealing with external comparisons. Control Clin Trials 1998; 19: 269-270.
28. Shuster JJ, Gieser PW. Meta-analysis and prospective meta-analysis in childhood leukemia: clinical research. Ann Oncol 1996; 7: 1009-1014.
29. Valsecchi MG, Masera G. A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. Ann Oncol 1996; 7: 1005-1008.